NRSN icon

NeuroSense Therapeutics

13 hedge funds and large institutions have $776K invested in NeuroSense Therapeutics in 2024 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
13
Holders Change
+6
Holders Change %
+85.71%
% of All Funds
0.17%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
7
Increased
3
Reduced
1
Closed
1
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
Citadel Advisors
1
Citadel Advisors
Florida
$305K +$264K +219,717 +641%
Morgan Stanley
2
Morgan Stanley
New York
$123K +$123K +102,581 New
Jane Street
3
Jane Street
New York
$77.6K +$77.6K +64,636 New
HF
4
HRT Financial
New York
$77K +$77K +64,390 New
XT
5
XTX Topco
Cayman Islands
$50.3K -$4.92K -4,099 -9%
MIH
6
Meitav Investment House
Israel
$48K
SWP
7
Stratos Wealth Partners
Ohio
$24K +$24K +20,000 New
Commonwealth Equity Services
8
Commonwealth Equity Services
Massachusetts
$20K +$4.46K +3,625 +29%
Geode Capital Management
9
Geode Capital Management
Massachusetts
$19K +$4.69K +3,907 +33%
TSS
10
Two Sigma Securities
New York
$18K +$18K +15,017 New
WAM
11
Warberg Asset Management
Illinois
$12.8K +$12.8K +10,700 New
Carson Wealth (CWM LLC)
12
Carson Wealth (CWM LLC)
Nebraska
$1K
SS
13
SBI Securities
Japan
$210 +$210 +175 New
CF
14
Cantor Fitzgerald
New York
-$101K -79,492 Closed